du-21220 has been researched along with Drug-Induced Stevens Johnson Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayabe, T; Fuse, Y; Hayashi, T; Higaki, H; Higaki, Y; Kido, K; Kikuchi, A; Matsumoto, S; Sasamori, Y; Shiba, M; Shinozuka, N; Taguchi, A; Umezawa, K | 1 |
| Claessens, N; Delbeke, L; Lafaire, C; Lambert, J; Matthieu, L; Van Marck, E | 1 |
2 other study(ies) available for du-21220 and Drug-Induced Stevens Johnson Syndrome
| Article | Year |
|---|---|
Erythematous and bullous rash strongly indicating toxic epidermal necrolysis associated with the use of intravenous ritodrine hydrochloride.
Topics: Adrenergic beta-Agonists; Adult; Blister; Cesarean Section; Erythema; Female; Glucocorticoids; Humans; Prednisolone; Pregnancy; Ritodrine; Stevens-Johnson Syndrome; Treatment Outcome | 2010 |
Toxic epidermal necrolysis associated with treatment for preterm labor.
Topics: Adult; Betamethasone; Female; Gestational Age; Glucocorticoids; Humans; Indomethacin; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications; Ritodrine; Stevens-Johnson Syndrome; Tocolysis; Tocolytic Agents | 1998 |